<DOC>
	<DOC>NCT00136799</DOC>
	<brief_summary>The purpose of the study is to evaluate the safety and tolerability of fluvastatin 80 mg in a Chinese population. This study is not recruiting patients in the US.</brief_summary>
	<brief_title>Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Fluvastatin</mesh_term>
	<criteria>Mixed dyslipidemia Primary hypercholesterolemia Pregnant or lactating women Age &gt; 18 years Other protocoldefined inclusion and exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Mixed Dyslipidemia</keyword>
	<keyword>high cholesterol</keyword>
	<keyword>adults</keyword>
	<keyword>fluvastatin</keyword>
</DOC>